Pharmaceutical products
Titre original de l'avis
Bulgaria-Sofia: Pharmaceutical products
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
40 / 100
Facteurs de risque
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- BGN 8.7M estimated value
- Supplies contract
- Supply of various pharmaceutical products to Pirogov Hospital, Sofia.
- Products are grouped into nomenclature units (sub-lots), but no detailed list provided in the notice.
Afficher le résumé complet
Establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to Pirogov Hospital in Sofia, Bulgaria. The DPS has an estimated total value of 8,695,574 BGN and a duration of 36 months (until 29 December 2026). This is a restricted procedure, with award based on lowest price. Eligibility includes a minimum turnover of 100,000 BGN over the last three years and possession of a wholesale distribution license. The notice is a DPS creation, and no specific lot breakdown is provided; the system covers multiple nomenclature units. Procurement documents were not analyzed.
Risques
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
No procurement documents available
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- No technical or professional capacity requirement is imposed.
Eligibility
- Minimum total turnover of 100,000 BGN over the last three financial years.
Certifications
- Tenderers must hold a wholesale distribution license for pharmaceuticals or equivalent, as per Bulgarian law.
Les exigences peuvent être incomplètes.
Acheteur
Localisation
гр. София, BGR
Site web
Profil acheteur
Identifiant
130345786
Activité
Health
Détails de la procédure
- Date de publication
- 02 Jan 2024
- Langues
- Bulgarian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 3311-2024
Appels d'offres similaires
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
40 / 100
Facteurs de risque
Procurement documents were not analyzed. Critical details (e.g., full product list, contract terms, technical specifica...
DPS may attract many bidders due to low barriers; price-only award increases competition.
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications